[go: up one dir, main page]

IN2012MU00206A - - Google Patents

Download PDF

Info

Publication number
IN2012MU00206A
IN2012MU00206A IN206MU2012A IN2012MU00206A IN 2012MU00206 A IN2012MU00206 A IN 2012MU00206A IN 206MU2012 A IN206MU2012 A IN 206MU2012A IN 2012MU00206 A IN2012MU00206 A IN 2012MU00206A
Authority
IN
India
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN206MU2012 priority Critical patent/IN2012MU00206A/en
Priority to US13/745,010 priority patent/US9283270B2/en
Publication of IN2012MU00206A publication Critical patent/IN2012MU00206A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN206MU2012 2012-01-20 2012-01-20 IN2012MU00206A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN206MU2012 IN2012MU00206A (en) 2012-01-20 2012-01-20
US13/745,010 US9283270B2 (en) 2012-01-20 2013-01-18 Method for stabilization of biological molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN206MU2012 IN2012MU00206A (en) 2012-01-20 2012-01-20

Publications (1)

Publication Number Publication Date
IN2012MU00206A true IN2012MU00206A (en) 2013-08-09

Family

ID=48945734

Family Applications (1)

Application Number Title Priority Date Filing Date
IN206MU2012 IN2012MU00206A (en) 2012-01-20 2012-01-20

Country Status (2)

Country Link
US (1) US9283270B2 (en)
IN (1) IN2012MU00206A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX364644B (en) 2012-11-21 2019-05-03 Serum Inst India Ltd Production of high yields of bacterial polysaccharides.
EP3283102A4 (en) 2015-04-16 2018-10-03 Inventprise, LLC. Bordetella pertussis immunogenic vaccine compositions
WO2016200787A2 (en) 2015-06-09 2016-12-15 The Board Of Regents Of The University Of Oklahoma Compositions and treatments for haemophilus influenzae
WO2017040885A1 (en) 2015-09-03 2017-03-09 The Board Of Regents Of The University Of Oklahoma Peptide inhibitors of clostridium difficile tcdb toxin
LT3506935T (en) 2016-09-02 2024-04-25 Sanofi Pasteur, Inc. Neisseria meningitidis vaccine
US11400162B2 (en) * 2017-02-24 2022-08-02 Merck Sharp & Dohme Llc Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
BR112020004410A8 (en) * 2017-09-07 2023-01-31 Merck Sharp & Dohme PROCESSES FOR THE FORMULATION OF PNEUMOCOCCAL POLYSACCHARIDES FOR CONJUGATION TO A CARRIER PROTEIN
CN107828360A (en) * 2017-11-16 2018-03-23 西安长峰机电研究所 A kind of normal temperature cure solid rocket motor nozzle structural adhesive
JP7570234B2 (en) * 2018-04-16 2024-10-21 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Additives for protein formulations to improve thermal stability
JOP20200214A1 (en) * 2019-09-03 2021-03-03 Serum Institute Of India Pvt Ltd Immunogen formulations against intestinal diseases and methods of their preparation
NL2023863B1 (en) * 2019-09-20 2021-05-25 Univ Griffith Protein particles and uses thereof
US12053515B2 (en) 2020-08-10 2024-08-06 Inventprise, Inc. Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F
WO2024233456A1 (en) 2023-05-05 2024-11-14 The Board Of Regents Of The University Of Oklahoma Variants of adrenomedullin (am) and adrenomedullin 2/intermedin (am2/imd) and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0487632T3 (en) 1989-08-15 1998-05-25 Massachusetts Inst Technology Stabilized vaccine compositions
WO1995017503A1 (en) 1993-12-21 1995-06-29 Merck & Co., Inc. Thermostable varicella zoster virus
AU725231B2 (en) 1996-12-20 2000-10-12 Merck & Co., Inc. Stabilisers for lyophilised vaccines
CN1053590C (en) 1998-10-19 2000-06-21 卫生部长春生物制品研究所 Frozen dried heptitis A toxicity-reduced bio-vaccine and protective agent thereof
JP4948731B2 (en) 1999-12-02 2012-06-06 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド Compositions and methods for stabilizing biological molecules during lyophilization
IN2009KN04098A (en) * 2007-06-04 2015-08-28 Novartis Ag
PT2200642E (en) * 2007-10-19 2012-05-30 Novartis Ag Meningococcal vaccine formulations
BRPI0800357A2 (en) 2008-03-10 2009-10-27 Fundacao Oswaldo Cruz method for producing a stabilized vaccine
WO2012020326A1 (en) * 2010-03-18 2012-02-16 Novartis Ag Adjuvanted vaccines for serogroup b meningococcus

Also Published As

Publication number Publication date
US9283270B2 (en) 2016-03-15
US20130209503A1 (en) 2013-08-15

Similar Documents

Publication Publication Date Title
BR112014017635A2 (en)
BR112014017614A2 (en)
BR112014017625A2 (en)
BR112014017659A2 (en)
BR112014017592A2 (en)
BR112014017646A2 (en)
BR112014017607A2 (en)
BR112014017638A2 (en)
BR112013027865A2 (en)
BR112014017609A2 (en)
BR112014017634A2 (en)
BR112014017644A2 (en)
BR112014017588A2 (en)
BR112014017618A2 (en)
BR112014017647A2 (en)
BR112014013184A8 (en)
BR112014017623A2 (en)
BR112014017652A2 (en)
BR112014017630A2 (en)
BR112014017627A2 (en)
IN2012MU00206A (en)
BR112014017621A2 (en)
BR112014017631A2 (en)
BR112014017641A2 (en)
BR112014017622A2 (en)